Hepatitis Australia has appointed Carrie Fowlie as its incoming Chief Executive Officer.

Following the retirement of Helen Tyrrell at the beginning of February, Hepatitis Australia undertook a rigorous recruitment process to identify the person to take over the operational leadership of the organisation and work closely with the Board.

Hepatitis Australia is pleased to announce Carrie Fowlie as the incoming CEO. 

Hepatitis Australia President, A/Prof. Grant Phelps said, “the Board is delighted that Carrie has accepted the position of CEO.  Carrie brings deep experience and knowledge of the sector and is well known to and highly regarded by many who have worked with Hepatitis Australia.”

“Carrie is very well positioned to assist the Board and staff of Hepatitis Australia to continue to drive towards improving the lives of people with hepatitis B and hepatitis C and our vision of an end to viral hepatitis in Australia”

Carrie heads to Hepatitis Australia with almost two decades of peak body experience.

Carrie has extensive representational experience at the national and international level. Her work with elected officials and their offices, in parliaments, at the United Nations and with government officials has resulted in policies that are consistent with the evidence and the priorities of the constituencies she has represented.

Carrie Fowlie said, “the leadership of Hepatitis Australia with its members, affected communities, the sector and allies over the past decade has been transformative.”

“What an extraordinary opportunity, working together to achieve a shared goal of eliminating viral hepatitis by 2030.”

“I look forward to contributing to the health and wellbeing and strengthening the voices of around 400,000 Australians living with hepatitis B or hepatitis C and those who represent them.”

Acting CEO, Kevin Marriott says, “the staff team at Hepatitis Australia is excited to welcome Carrie and we look forward to her leadership and guidance into the future.

Carrie Fowlie will formally commence with Hepatitis Australia in mid-April.

Download a copy of the Media Statement